Placing Very Elderly Patients on RRT
An Update on New Therapies for mCRPC: An Interview with Oliver Sartor, MD
Recent therapeutic advances in metastatic renal cell carcinoma (RCC) have included agents targeted against vascular endothelial growth factor (VEGF).
